Endocrinology, Vol 118, 968-973, Copyright © 1986 by Endocrine Society

ARTICLES

Growth factors suppress and phorbol esters potentiate the action of dibutyryl adenosine 3',5'-monophosphate to stimulate aromatase activity of human adipose stromal cells

CR Mendelson, CJ Corbin, ME Smith, J Smith and ER Simpson

In previous studies, we observed that the stimulatory effect of (Bu)2cAMP on aromatase activity of human adipose stromal cells was markedly attenuated when fetal calf serum was present in the culture medium. To determine whether growth factors may be the inhibitors of (Bu)2cAMP-stimulated aromatase activity in serum, the effects of growth factors and phorbol esters on aromatase activity of human adipose stromal cells in monolayer culture were investigated. Epidermal growth factor (EGF), fibroblast growth factor (FGF), and platelet-derived growth factor (PDGF) were all without effect on aromatase activity when added by themselves, but markedly inhibited aromatase activity stimulated by (Bu)2cAMP. On the other hand, nerve growth factor, multiplication-stimulating activity, relaxin, and insulin had no effect on aromatase activity, either by themselves or in the presence of (Bu)2cAMP. Thus, EGF, PDGF, and FGF can mimic the inhibitory action of fetal calf serum on (Bu)2cAMP-stimulated aromatase activity of these cells. By contrast, none of these substances was capable of mimicking the effect of serum to facilitate the stimulatory action of dexamethasone on aromatase activity of these cells. The phorbol esters phorbol-12-myristate-13-acetate, phorbol-12,13-didecanoate, and phorbol- 12,13-diacetate were also capable of facilitating the action of (Bu)2cAMP to stimulate aromatase activity, but had little or no action on dexamethasone-stimulated aromatase activity or when added by themselves. It is concluded that aromatase is under multifactorial regulation in human adipose stromal cells. The activity is induced by glucocorticoids and by agents that stimulate cAMP-dependent protein kinase; the latter effect is potentiated by factors that stimulate protein kinase C, but is suppressed by growth factors such as EGF, FGF, and PDGF, whose actions are believed to be mediated by receptor-linked tyrosine kinase activity.

This article has been cited by other articles:

				D. Chen, S. Reierstad, Z. Lin, M. Lu, C. Brooks, N. Li, J. Innes, and S. E. Bulun Prostaglandin E2 Induces Breast Cancer Related Aromatase Promoters via Activation of p38 and c-Jun NH2-Terminal Kinase in Adipose Fibroblasts Cancer Res., September 15, 2007; 67(18): 8914 - 8922. [Abstract] [Full Text] [PDF]

				S. Ghosh, Y. Lu, A. Katz, Y. Hu, and R. Li Tumor suppressor BRCA1 inhibits a breast cancer-associated promoter of the aromatase gene (CYP19) in human adipose stromal cells Am J Physiol Endocrinol Metab, January 1, 2007; 292(1): E246 - E252. [Abstract] [Full Text] [PDF]

				G. L. Rubin, J. H. Duong, C. D. Clyne, C. J. Speed, Y. Murata, C. Gong, and E. R. Simpson Ligands for the Peroxisomal Proliferator-Activated Receptor {gamma} and the Retinoid X Receptor Inhibit Aromatase Cytochrome P450 (CYP19) Expression Mediated by Promoter II in Human Breast Adipose Endocrinology, August 1, 2002; 143(8): 2863 - 2871. [Abstract] [Full Text] [PDF]

				M. HERRMANN, J. SCHOLMERICH, and R. H. STRAUB Influence of Cytokines and Growth Factors on Distinct Steroidogenic Enzymes in Vitro: A Short Tabular Data Collection Ann. N.Y. Acad. Sci., June 1, 2002; 966(1): 166 - 186. [Abstract] [Full Text] [PDF]

				R. J. Pauley, S. J. Santner, L. R. Tait, R. K. Bright, and R. J. Santen Regulated CYP19 Aromatase Transcription in Breast Stromal Fibroblasts J. Clin. Endocrinol. Metab., February 1, 2000; 85(2): 837 - 846. [Abstract] [Full Text]

				T. Morimoto, J. R. Head, P. C. MacDonald, and M. L. Casey Thrombospondin-1 Expression in Human Myometrium before and during Pregnancy, before and during Labor, and in Human Myometrial Cells in Culture Biol Reprod, October 1, 1998; 59(4): 862 - 870. [Abstract] [Full Text]

				N. Harada, H. Ota, N. Yoshimura, T. Katsuyama, and Y. Takagi Localized Aberrant Expression of Cytochrome P450 Aromatase in Primary and Metastatic Malignant Tumors of Human Liver J. Clin. Endocrinol. Metab., February 1, 1998; 83(2): 697 - 702. [Abstract] [Full Text]

				L. Gnessi, A. Fabbri, and G. Spera Gonadal Peptides as Mediators of Development and Functional Control of the Testis: An Integrated System with Hormones and Local Environment Endocr. Rev., August 1, 1997; 18(4): 541 - 609. [Abstract] [Full Text] [PDF]

				L. S. Noble, K. Takayama, K. M. Zeitoun, J. M. Putman, D. A. Johns, M. M. Hinshelwood, V. R. Agarwal, Y. Zhao, B. R. Carr, and S. E. Bulun Prostaglandin E2 Stimulates Aromatase Expression in Endometriosis-Derived Stromal Cells J. Clin. Endocrinol. Metab., February 1, 1997; 82(2): 600 - 606. [Abstract] [Full Text] [PDF]

				D. Zhou, P. Clarke, J. Wang, and S. Chen Identification of a Promoter That Controls Aromatase Expression in Human Breast Cancer and Adipose Stromal Cells J. Biol. Chem., June 21, 1996; 271(25): 15194 - 15202. [Abstract] [Full Text] [PDF]

				K. Yamada, N. Harada, S.-i. Honda, and Y. Takagi Regulation of Placenta-specific Expression of the Aromatase Cytochrome P-450 Gene J. Biol. Chem., October 20, 1995; 270(42): 25064 - 25069. [Abstract] [Full Text] [PDF]